2012 UK antenatal pertussis vaccination campaign
This article is a stub. Please feel free to expand it and make it more encyclopaedic.
See also main Pertussis page.
The reason for the campaign is that there has, since the second half of 2011 been an increase in notifications of whooping cough.
Given that the most serious complications of - and nearly all of the deaths from - whooping cough arise in small infants, particularly those younger than 3 months, who are too young to have been vaccinated and to have active immunity against the disease, the purpose of the campaign is to:
- Provide direct protection to neonates by ensuring high levels of circulating maternal antibody from 34 weeks in pregnancy - the period in which most maternal antibody passage happens.
- Provide indirect protection to neonates by protecting the mother from whooping cough, so that she cannot pass the disease on to the baby. (About 75% of babies catch their pertussis from a parent or other household member. Most of the remaining 25% catch it from a health care worker.)
See HPA pertussis page - information on figures is available via the "Epidemiological Data" link.
- HPA web site with links to other key resources, including those listed below, and to an excellent HPA Questions and Answers document.
- Page from Department of Health linking to:
- Resources to support whooping cough vaccination programme for pregnant women from Department of Health. (These are excellent; and the information sheet will also be very useful for healthcare professionals). On 1 October 2012 they comprise[d]:
- a leaflet that goes into detail about the vaccination programme in a question and answer format: Whooping cough and pregnancy: Your questions answered on how to help protect your baby
- a flyer aimed at expectant mothers, explaining what they will need to know before having the vaccination Whooping cough: What you need to know and do to help protect your baby
- a factsheet that gives the scientific background to the need for, and development of, the vaccination programme: Pertussis (whooping cough) immunisation for pregnant women
- a poster: Whooping cough and pregnancy: Poster – Help protect your baby
- PGDs - some have been circulated at/via Vaccimmuk. Others may be uploaded to the PGD portal of the National Electronic Library of Medicine.
- The NHS Education for Scotland web site hosts the following (excellent) Health Protection Scotland resources:
- Vaccination of pregnant women against pertussis: background information.
- Vaccination against pertussis (whooping cough) - the use of Repevax: an update for healthcare professionals.
- Vaccination against pertussis (whooping cough) - the use of Repevax: an update for midwifery
- Vaccination of pregnant women against pertussis: questions and answers
- David Salisbury talking about the Pertussis 'whooping cough' vaccination programme
- Press statement from Department of Health.
- HPR report announcing the campaign, with useful background information.
- Piece (podcast) on Pertussis written before this campaign was announced, but which provides some background. (At 42:26) - script and additional notes etc here.
- Details about Repevax from the SPC.
- US guidance on vaccination in pregancy from Centers for Disease Control and Prevention
Key points from the CMO and NHS Chief Executive letters
- There's a nationally agreed service specification for GPs
- "We have…sufficient stocks of [pertussis vaccine]"
- "Vaccination will need to be undertaken wherever antenatal care is provided…".
- The vaccine that should be used is Repevax, which is also used as a pre-school booster. Revaxis should NOT be used.
- Vaccines to be ordered in the normal way, via ImmForm
- Practices are expected to start by using the supplies of Repevax that they already have in stock, and to put in new orders, if needed, in the usual way.
- "We will run a communications campaign… from the end of October until February"
- A range of materials will be available… via www.immunisation.dh.gov.uk
- "A set of power point training slides will be made available"
- Vaccination to be offered from 28 weeks until onset of labour
- "There is no evidence of risk to pregnancy or the infant…Use…in pregnancy is not contraindicated"
- Women who become pregnant again while the programme is in place should be offered immunisation during each pregnancy… with a gap of at least one month between immunisations.
- "Very few medical reasons why Repevax should not be given…[it] is suitable of those with an egg allergy".
- "Having a minor illness without a fever (e.g. a cold) is not a reason to delay immunisation"
- Details on National Enhance Service (NES) in Florey letter
- "GP practices…will receive £7.67 per dose of vaccine given"
- PCTs and GP practices may wish to agree local arrangements…to involve midwives"
- DH "will provide funding for PCTs to cover the additional costs of vaccine supplies and administration in 2012/132
- "Should…programme continue in 2013/14…funding…incl. In NHSCB’s budget…& contracts agreed with GP practices or other providers will transfer to the Boards’ Local Area Teams…
- "NES applies from 1/10/12 for as long as the temporary programme continues to be advised"
- "Contractors may also offer vaccination beyond week 38, including new mothers who missed the opportunity to be vaccinated during preganancy and who have not previously been vaccinated…"
- "Contractors may also offer vaccination beyond week 38, including new mothers who… missed the opportunity to be vaccinated during pregnancy and who have not previously been vaccinated…"
- "Contractors may also offer vaccination beyond week 38, including new mothers who missed the opportunity to be vaccinated during pregnancy and who have not previously been vaccinated…" (This is taken to refer to women who have never completed a course of pertussis vaccination. Women who have not (ever) completed a course of pertussis containing vaccine should be have a partial course completed, or given a full course of pertussis-containing vaccine if they had never started a course. This applies from the time they fall pregnant, until their child has had its first dose of vaccine - usually at or shortly after 8 weeks of age.)
- "Take all reasonable steps to ensure that the medical records of patients … are kept up to date, [including]"
- Any refusal of an offer of vaccination
- Batch No, expiry date, title of vaccine
- Date of administration
- Where two vaccines administered in close succession (e.g. pertussis and flu) the route of admin and injection site of each
- Any contraindication
- Any adverse reactions
- ↑ Davies S, Bennett VJ, Ridge KW. Temporary programme of pertussis (whooping cough) vaccination of pregnant women. London: Department of Health, 2012 (27 September); 1-10.
- ↑ Flory D. Commissioning the pertussis (whooping cough) vaccination programme for pregnant women. London: Department of Health, 2012 (28 September); 1-6.
- ↑ Health Protection Scotland. Vaccination of pregnant women against pertussis: background information. Glasgow: Health Protection Scotland, 2012 (October); 1-17
- ↑ Health Protection Scotland. Vaccination against pertussis (whooping cough) - the use of Repevax: an update for healthcare professionals. Glasgow: Health Protection Scotland, 2012 (October); 1-38.
- ↑ Health Protection Scotland. Vaccination against pertussis (whooping cough) - the use of Repevax: an update for midwifery. Glasgow: Health Protection Scotland, 2012 (October); 1-38.
- ↑ Health Protection Scotland. Vaccination of pregnant women against pertussis: questions and answers. Glasgow: Health Protection Scotland, 2012 (October); 1-8.
- ↑ Department of Health. Newborns to be protected against whooping cough. 2012; London: Department of Health, Updated 28 September 2012; Accessed: 2012 (28 September): Press statement about antenatal whooping cough vaccination campaign
- ↑ Health Protection Agency. DH recommends pertussis vaccination for pregnant women. Health Protection Report 2012;6(39).